Hurrell, Tracey; Outhoff, Kim
(Dove Medical Press, 2013-06-15)
INTRODUCTION: Despite trastuzumab having enhanced selectivity for human epidermal growth factor receptor 2 (HER-2) overexpressing breast cancer cells, treatment is hampered by interindividual variation and tumors with high ...